Acrivon Therapeutics, Inc. Common Stock ACRV
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Wiaczeslaw Smolokowski | CYPRUS | 0 | 3848632 | 0 | 3848632 | 3848632 | 12.5 % | 10/07/2024 |
| Chione Limited | CYPRUS | 0 | 3848632 | 0 | 3848632 | 3848632 | 12.5 % | 10/07/2024 |
| Marcin Czernik | POLAND | 0 | 3848632 | 0 | 3848632 | 3848632 | 12.5 % | 10/07/2024 |
| Andreas Hadjimichael | CYPRUS | 0 | 3848632 | 0 | 3848632 | 3848632 | 12.5 % | 10/07/2024 |
| Anastasis Nikolaou | CYPRUS | 0 | 3848632 | 0 | 3848632 | 3848632 | 12.5 % | 10/07/2024 |
| Chione Limited | CYPRUS | 0 | 3848632 | 0 | 3848632 | 3848632 | 17.3 % | 10/07/2024 |
| Marcin Czernik | POLAND | 0 | 3848632 | 0 | 3848632 | 3848632 | 17.3 % | 10/07/2024 |
| Andreas Hadjimichael | CYPRUS | 0 | 3848632 | 0 | 3848632 | 3848632 | 17.3 % | 10/07/2024 |
| Anastasis Nikolaou | CYPRUS | 0 | 3848632 | 0 | 3848632 | 3848632 | 17.3 % | 10/07/2024 |
| Wiaczeslaw Smolokowski | CYPRUS | 0 | 3848632 | 0 | 3848632 | 3848632 | 17.3 % | 10/07/2024 |
| Marshall Wace North America L.P. | Delaware | 0 | 1223252 | 0 | 1223252 | 1223252 | 5.9 % | 14/02/2023 |
| Andreas Hadjimichael | CYPRUS | 0 | 3856597 | 0 | 3856597 | 3856597 | 18.5 % | 28/11/2022 |
| Anastasis Nikolaou | CYPRUS | 0 | 3856597 | 0 | 3856597 | 3856597 | 18.5 % | 28/11/2022 |
| Chione Limited | CYPRUS | 0 | 3856597 | 0 | 3856597 | 3856597 | 18.5 % | 28/11/2022 |
| Wiaczeslaw Smolokowski | CYPRUS | 0 | 3856597 | 0 | 3856597 | 3856597 | 18.5 % | 28/11/2022 |
| Marcin Czernik | POLAND | 0 | 3856597 | 0 | 3856597 | 3856597 | 18.5 % | 28/11/2022 |
| Sands Capital Life Sciences Pulse Fund II, L.P. | Cayman Islands | 0 | 1652606 | 0 | 1652606 | 1652606 | 7.9 % | 25/11/2022 |
| Frank M. Sands | United States of America | 0 | 1652606 | 0 | 1652606 | 1652606 | 7.9 % | 25/11/2022 |
| Citadel Securities GP LLC | Delaware | 0 | 4006 | 0 | 4006 | 4006 | 0 % | 21/11/2022 |
| Kenneth Griffin | U.S. Citizen | 0 | 1634637 | 0 | 1634637 | 1634637 | 7.8 % | 21/11/2022 |
| Citadel Advisors LLC | Delaware | 0 | 1630631 | 0 | 1630631 | 1630631 | 7.8 % | 21/11/2022 |
| Citadel Advisors Holdings LP | Delaware | 0 | 1630631 | 0 | 1630631 | 1630631 | 7.8 % | 21/11/2022 |
| Citadel GP LLC | Delaware | 0 | 1630631 | 0 | 1630631 | 1630631 | 7.8 % | 21/11/2022 |
| Citadel Securities LLC | Delaware | 0 | 4006 | 0 | 4006 | 4006 | 0 % | 21/11/2022 |
| Citadel Securities Group LP | Delaware | 0 | 4006 | 0 | 4006 | 4006 | 0 % | 21/11/2022 |
| Joseph Edelman | United States of America | 0 | 3007858 | 0 | 3007858 | 3007858 | 14.4 % | 18/11/2022 |
| Perceptive Advisors LLC | Delaware | 0 | 3007858 | 0 | 3007858 | 3007858 | 14.4 % | 18/11/2022 |
| Perceptive Life Sciences Master Fund, Ltd. | Cayman Islands | 0 | 3007858 | 0 | 3007858 | 3007858 | 14.4 % | 18/11/2022 |